Statement of Cash Flows (Unaudited) - USD ($)	5 Months Ended	9 Months Ended
	Sep. 30, 2021	Sep. 30, 2022
Cash flows from operating activities:
Net income (loss)	$ (15,650)	$ 398,558
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Interest earned in trust account		(680,827)
Amortization		78,134
Net changes in operating assets & liabilities:
Deferred offering costs	(114,747)	236,522
Prepaid expenses		(157,500)
Accrued offering costs	26,450	(31,550)
Accrued expenses		78,828
Net cash used in operating activities	(103,947)	(77,835)
Cash flows from investing activities:
Investment of cash in Trust Account		(115,000,000)
Net cash used in investing activities		(115,000,000)
Cash flows from financing activities:
Borrowing to related party	300,000
Proceeds from issuance of Founder Shares to Sponsor	25,000
Proceeds from sale of private placement units		3,300,000
Proceeds from sale of Units		114,700,000
Payment of offering costs		(2,829,741)
Net cash provided by financing activities	325,000	115,170,259
Net increase in cash and cash equivalents	221,053	92,424
Cash and cash equivalents at beginning of period		95,978
Cash and cash equivalents at end of period	221,053	188,402
Supplemental disclosure of non-cash investing and financing Activities:
Deferred offering costs included in accrued offering cost	26,450
Defer underwriting compensation		2,875,000
Initial value of ordinary stock subject to possible redemption		101,200,000
Reclassification of offering costs related to public shares		(5,020,172)
Change in value of ordinary shares subject to redemption		18,820,172
Subsequent measurement of ordinary shares subject to redemption (interest earned on trust account)		$ 680,827